Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

AEterna Zentaris to advance cetrorelix into phase III for BPH

June 23, 2006

New fixed-dose formulations for BPH described in recent GSK patent

June 22, 2006

Toray granted Japanese license to AC-200

June 21, 2006

Sanctura XR reduces symptoms of overactive bladder

June 19, 2006

Pfizer completes acquisition of fesoterodine rights from Schwarz Pharma

June 19, 2006

Novel agents for urological disorders disclosed in recent patent literature

June 13, 2006

Cialis Once-A-Day submitted for European review

June 9, 2006

Japanese launch for Detrusitol for overactive bladder

June 8, 2006

Vesicare to be launched in Japan

June 2, 2006

Novel alpha 1a/1d adrenoreceptor antagonists claimed for BPH treatment

May 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...